These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3926900)

  • 21. Binding of interleukin 2 to target cells: determination of high and low affinity binding sites on T-lymphoblasts by differential dissociation.
    Horst HJ; Flad HD
    Clin Exp Immunol; 1985 Dec; 62(3):579-85. PubMed ID: 3936657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 2 binding capacity of human mononuclear leukocytes.
    Horst HJ; Flad HD
    Lymphokine Res; 1986; 5 Suppl 1():S55-9. PubMed ID: 3097428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human interleukin 2.
    Robb RJ
    Methods Enzymol; 1985; 116():493-525. PubMed ID: 3937027
    [No Abstract]   [Full Text] [Related]  

  • 24. Structure-function relationships for the IL 2-receptor system. I. Localization of a receptor binding site on IL 2.
    Kuo LM; Robb RJ
    J Immunol; 1986 Sep; 137(5):1538-43. PubMed ID: 2427572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
    Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
    J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 2 functions through novel interleukin 2 binding molecules in T cells.
    Tanaka T; Saiki O; Doi S; Negoro S; Kishimoto S
    J Immunol; 1988 Jan; 140(2):470-3. PubMed ID: 2826593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL 2 receptor induction on human T lymphocytes: role for IL 2 and monocytes.
    Wakasugi H; Bertoglio J; Tursz T; Fradelizi D
    J Immunol; 1985 Jul; 135(1):321-7. PubMed ID: 2987347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 2 and its cell-surface receptor.
    Robb RJ
    Behring Inst Mitt; 1985 Aug; (77):56-67. PubMed ID: 3936474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.
    Robb RJ; Greene WC
    J Exp Med; 1983 Oct; 158(4):1332-7. PubMed ID: 6413637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 2: a review.
    Kolitz JE; Welte K; Sykora KW; Mertelsmann R
    Arzneimittelforschung; 1985; 35(10):1607-15. PubMed ID: 3000391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the cell surface receptors for human B cell growth factor of 12,000 molecular weight.
    Mehta SR; Grant SR; Maizel AL
    J Immunol; 1986 Oct; 137(7):2210-4. PubMed ID: 3093567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of IL 2-dependent proliferation despite significant expression of high-affinity IL 2 receptor on murine cytolytic T lymphocyte clones late after antigenic stimulation.
    Churilla AM; Braciale VL
    J Immunol; 1987 Mar; 138(5):1338-45. PubMed ID: 3100636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of biologically active interleukin-1 by a soluble receptor binding assay.
    Riske F; Chizzonite R; Nunes P; Stern AS
    Anal Biochem; 1990 Mar; 185(2):206-12. PubMed ID: 2140248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism whereby ouabain inhibits human T lymphocyte activation: effect on the interleukin 2 pathway.
    Dornand J; Favero J; Bonnafous JC; Mani JC
    Immunobiology; 1986 Jul; 171(4-5):436-50. PubMed ID: 3091487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.
    Voss SD; Sondel PM; Robb RJ
    J Exp Med; 1992 Aug; 176(2):531-41. PubMed ID: 1500859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cyclosporine on interleukin 2 receptor expression in a human alloreactive T cell clone.
    Chabannes D; Le Mauff B; Hallet MM; Yacques Y; Soulillou JP
    Transplantation; 1988 Aug; 46(2 Suppl):97S-100S. PubMed ID: 3136569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
    Reed JC; Greene WC; Hoover RG; Nowell PC
    J Immunol; 1985 Oct; 135(4):2478-82. PubMed ID: 3928749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS; Malek TR; Hargrove ME; Ting CC
    J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-2 and the IL-2 receptor: new insights into structure and function.
    Kuziel WA; Greene WC
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):27S-32S. PubMed ID: 1693645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of a receptor binding site on the IL-2 molecule.
    Bubeník J; Krchnák V; Indrová M; Hamsíková E; Jandlová T; Símová J; Kieler J
    Folia Biol (Praha); 1987; 33(4):266-81. PubMed ID: 2444471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.